Copyright: ©Author(s) 2026.
World J Gastroenterol. Oct 7, 2026; 32(37): 119222
Published online Oct 7, 2026. doi: 10.3748/wjg.119222
Published online Oct 7, 2026. doi: 10.3748/wjg.119222
Figure 1 Preferred reporting items for systematic reviews and meta-analyses 2020 flow diagram illustrating the study selection process.
Twelve studies were included in both the qualitative and quantitative synthesis. RCT: Randomized controlled trial; H. pylori: Helicobacter pylori; L. reuteri: Limosilactobacillus reuteri.
- Citation: Francavilla R, Iannone A, Cristofori F, Cafforio A, Dargenio VN, La Grasta G, Brindicci VF, Castellaneta SP, Barone M. Limosilactobacillus reuteri DSM 17938 and PTA 6475 as adjunct in Helicobacter pylori therapy: Systematic review and meta-analysis. World J Gastroenterol 2026; 32(37): 119222
- URL: https://www.wjgnet.com/1007-9327/full/v32/i37/119222.htm
- DOI: https://dx.doi.org/10.3748/wjg.119222